Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03498586 · ClinicalTrials.gov registry record · NA
Half-normal Saline in Atrial Fibrillation Ablation
A NA study, sponsored by Texas Cardiac Arrhythmia Research Foundation.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT03498586 is a NA study that has completed, run by Texas Cardiac Arrhythmia Research Foundation. The registered enrollment target is 99 participants.
The verdict
NCT03498586, a NA study, has completed, sponsored by Texas Cardiac Arrhythmia Research Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
The study evaluates the use of half-normal saline as an irrigant for open-irrigated catheters during atrial fibrillation ablation. By increasing the efficacy of radiofrequency energy-mediated lesion formation, half-normal saline has the potential to reduce procedural times and improved acute and long-term outcomes.
Interventions
- DRUG Normal saline
- DRUG Half-normal saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2018-05-02 |
| Est. Completion | 2020-05-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03498586
The ClinicalTrials.gov registry entry for NCT03498586 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Cardiac Arrhythmia Research Foundation, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal saline is the first listed.
NCT03498586 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03498586 about?
NCT03498586 is a clinical study titled "Half-normal Saline in Atrial Fibrillation Ablation". The study evaluates the use of half-normal saline as an irrigant for open-irrigated catheters during atrial fibrillation ablation. By increasing the efficacy of radiofrequency energy-mediated lesion formation, half-normal saline has the potential to reduce procedural times and improved acute and lon...
What is the current status of trial NCT03498586?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2018-05-02. Estimated completion is 2020-05-02.
What interventions are being tested in trial NCT03498586?
The interventions under investigation include: Normal saline (DRUG), Half-normal saline (DRUG).
Who is sponsoring clinical trial NCT03498586?
This trial is sponsored by Texas Cardiac Arrhythmia Research Foundation, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.